Concepedia
Statistics
Publications
5
Citations
1.5K
H-Index
Active since
2014
Affiliations
Agilent Technologies (United States)(Current)
Thermo Fisher Scientific (United States)
Binghamton University
Benjamin D. Lunstad is an author at Agilent Technologies (United States) specializing in crispr, gene editing, and gene expression.
Top concepts
CrisprMedicineGene EditingGenome EditingGene ExpressionSystems BiologyMolecular BiologyGenome EngineeringGenetic EngineeringEngineering
Publications per year
2014–2022
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Ayal Hendel, Rasmus O. Bak, Joseph T. Clark et al. · Nature Biotechnology · 2015 · 1.1K citations · Full text
Natural Sciences, Genetic Engineering, Molecular Biology +9
Improving CRISPR–Cas specificity with chemical modifications in single-guide RNAs
Daniel E. Ryan, David Taussig, Israel Steinfeld et al. · Nucleic Acids Research · 2017 · 268 citations · Full text
Systems Biology, Engineering, Off-target Effect +14
Amides are excellent mimics of phosphate internucleoside linkages and are well tolerated in short interfering RNAs
Daniel Mutisya, Chelliah Selvam, Benjamin D. Lunstad et al. · Nucleic Acids Research · 2014 · 60 citations · Full text
Synthesis, biophysical studies and RNA interference activity of RNA having three consecutive amide linkages
Paul Tanui, Scott D. Kennedy, Benjamin D. Lunstad et al. · Organic & Biomolecular Chemistry · 2014 · 26 citations · Full text
Phosphonoacetate Modifications Enhance the Stability and Editing Yields of Guide RNAs for Cas9 Editors
Daniel E. Ryan, Tamar Diamant-Levi, Israel Steinfeld et al. · Biochemistry · 2022 · 19 citations · Full text
1–5 of 5